CXCL8 and colonic neoplasm: Consistently, treatment with the NFAT inhibitory peptide VIVIT almost completely abolished SKAP1‐induced CXCL8 expression (Figure 6E), suggesting that SKAP1 dependents on NFATc1 to increase CXCL8 expression in colon cancer cells.